JORNAY PM 40 mg 24HR Extended Release Oral Capsule
RxNorm 2168869
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2168869 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: JORNAY PM 40 mg 24HR Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Evening Dosing 24 HR Jornay 40 mg Extended Release Oral Capsule
(Atom ID: 11417713)
SBDPrescribable
Semantic Branded Drug (SBD):
Evening Dosing 24 HR methylphenidate hydrochloride 40 mg Extended Release Oral Capsule [Jornay]
(Atom ID: 12372108)
PSNPrescribable
Prescribable Name (PSN):
JORNAY PM 40 mg 24HR Extended Release Oral Capsule
(Atom ID: 11417836)
SYPrescribable
Synonym (SY):
Jornay PM 40 mg 24HR Extended Release Oral Capsule
(Atom ID: 11417732)
Patient Education
Methylphenidate
Methylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Methylphenidate (Methylin) is also used to treat narcolepsy (a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep). Methylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by changing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.